Update on drug interactions with non-vitamin-K-antagonist oral anticoagulants for stroke prevention in elderly patients
C Stoellberger, J Finsterer - Expert Review of Clinical …, 2021 - Taylor & Francis
Introduction: We update the knowledge, since the last review in 2017, about drug–drug
interactions (DDI) of non-vitamin-K-antagonist oral anticoagulants (NOAC) in patients≥ 75 …
interactions (DDI) of non-vitamin-K-antagonist oral anticoagulants (NOAC) in patients≥ 75 …
Drug-drug interactions with direct oral anticoagulants for the prevention of ischemic stroke and embolism in atrial fibrillation: a narrative review of adverse events
C Stöllberger, B Schneider… - Expert Review of Clinical …, 2023 - Taylor & Francis
Introduction In randomized trials, direct oral anticoagulants (DOAC) were non-inferior to the
vitamin-K-antagonist (VKA) warfarin in preventing stroke/embolism in patients with atrial …
vitamin-K-antagonist (VKA) warfarin in preventing stroke/embolism in patients with atrial …
Sex hormones, related compounds and hormonal contraceptives including miscellaneous hormones
I Wells, S Ezzet, N Kalia, K Pawa, SD Ray - Side Effects of Drugs Annual, 2020 - Elsevier
Abstract The Side Effects of Drugs Annuals is a series of volumes in which the adverse
effects of drugs and adverse reactions to them are surveyed. The series supplements the …
effects of drugs and adverse reactions to them are surveyed. The series supplements the …
[PDF][PDF] Thrombophilia and Cardiac Thrombi
EB Simon - Clin Rev Cases, 2020 - scivisionpub.com
Thrombotic episodes of under 40-50 years of age is rare without a thrombophilia and
thrombus formation in the cardiac chambers is extremely rare compared to arterial and …
thrombus formation in the cardiac chambers is extremely rare compared to arterial and …